| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.0015 |
1 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
8e-05 |
| mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |